CORB.F Stock Overview
Provides umbilical cord blood storage and ancillary services in the People's Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Global Cord Blood Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.25 |
| 52 Week High | US$2.33 |
| 52 Week Low | US$0.85 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 23.76% |
| 1 Year Change | 0% |
| 33 Year Change | -70.59% |
| 5 Year Change | -74.80% |
| Change since IPO | -79.10% |
Recent News & Updates
Recent updates
Global Cord Blood GAAP EPS of $0.14, revenue of $46.88M
Jul 05Pounce On Global Cord For The Year Of The Tiger
Apr 29Global Cord Blood Corp. Looks Anemic On Slow Growth, Regulatory Concerns
Apr 08Global Cord Blood: With 6.0x P/E And 24% EPS CAGR, Subscriber Growth Continues
Dec 01Global Cord Blood Is An Undervalued Business With Accelerating Growth, Benefiting From China's Policy Changes
Jul 30Global Cord Blood: New China Policy Catalyst, 146% Net Cash And 24% EPS CAGR
Jul 01Global Cord Blood announces NHC policy update
Jan 05Global Cord Blood reports FQ2 results
Nov 24Shareholder Returns
| CORB.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -4.6% | -1.2% |
| 1Y | 0% | 1.1% | 30.4% |
Return vs Industry: CORB.F underperformed the US Healthcare industry which returned 1.1% over the past year.
Return vs Market: CORB.F underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| CORB.F volatility | |
|---|---|
| CORB.F Average Weekly Movement | 27.5% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CORB.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CORB.F's weekly volatility has increased from 21% to 28% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Tina Zheng | www.globalcordbloodcorp.com |
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province.
Global Cord Blood Corporation Fundamentals Summary
| CORB.F fundamental statistics | |
|---|---|
| Market cap | US$167.39m |
| Earnings (TTM) | US$69.21m |
| Revenue (TTM) | US$171.73m |
0.0x
P/E Ratio0.0x
P/S RatioIs CORB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CORB.F income statement (TTM) | |
|---|---|
| Revenue | CN¥1.24b |
| Cost of Revenue | CN¥183.31m |
| Gross Profit | CN¥1.06b |
| Other Expenses | CN¥558.88m |
| Earnings | CN¥501.07m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CORB.F perform over the long term?
See historical performance and comparison